New Delhi, July 29 (IANS) Certain non-statin cholesterol-lowering medications may reduce the risk of liver cancer, according to a study on Monday. The study, published online in the journal CANCER, suggests a potential protective effect of these medications, adding to existing evidence from past research on statins. The study, led by the National Cancer Institute of the Maryland National Institute of Health, focussed on five types of non-statin cholesterol-lowering drugs: Cholesterol absorption inhibitors, bile acid sequestrants, fibrates, niacin, and omega-3 fatty acids. These drugs are commonly prescribed to manage cholesterol and lipid levels, each operating through different mechanisms.
Hence then, the article about non statin cholesterol lowering drugs linked to lower liver cancer risk was published today ( ) and is available onNews room odisha ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Non-statin cholesterol-lowering drugs linked to lower liver cancer risk )